how is digital currency valued Reviews

Analysis: the potential weakness of Canada's manufacturing industry still exists. Forexlive: Canada's manufacturing industry rebounded strongly, mainly driven by petroleum products and automobiles. However, the year-on-year data decline shows that some potential weakness still exists.Daye shares: the proposed acquisition of 100% equity of Al-Kogerte GmbH constitutes a major asset restructuring. Daye shares announced that the company intends to acquire 100% equity of Al-Kogerte GmbH in cash through its wholly-owned subsidiary RUNBO INT PTE.LTD, which constitutes a major asset restructuring of the company.Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.

Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.Donghua Technology: Inner Mongolia New Materials, a holding subsidiary, signed a product sales contract with Yulin Chemical of Shaanxi Coal Group. Donghua Technology announced that China National Chemical New Materials Co., Ltd., a holding subsidiary, plans to sign a Product Sales Contract with Yulin Chemical Co., Ltd. of Shaanxi Coal Group, stipulating that Yulin Chemical will sell ethylene glycol and by-products produced by Inner Mongolia New Materials. The contract is from October 20, 2024 to December 31, 2025. Product prices are divided into temporary pricing and settlement price, and are priced according to the principle of marketization. From the beginning of 2024 to the disclosure date, the Company had related transactions with Yulin Chemical and its concerted parties, mainly to provide engineering services to Yulin Chemical and its concerted parties, with the related transactions amounting to 438 million yuan.The Bank of Italy said that the economy may only grow by 0.5% this year, and the Bank of Italy said in a statement on Friday that the gross domestic product (GDP) will increase by 0.5% in 2024. If seasonal and calendar effects are not taken into account, this figure will increase to 0.7%, but it is lower than the government's estimate of 1% in the budget. In addition, GDP growth is expected to be 0.8% in 2025 and 1.1% in 2026. It is estimated that the unified average inflation rate in the EU will be 1.1% in 2024, which is the same as the estimated value in October, 1.5% in 2025 and 1.6% in 2025.

Canada recorded a monthly wholesale sales rate of 1% in October, the largest increase since April 2024. Canada recorded a monthly wholesale sales rate of 1% in October, with an expected 0.5% and a previous value of 0.80%. Canada's annual wholesale sales rate in October was 1.7%, and the previous value was -0.4%. Canada's annual wholesale inventory rate in October was -1%, and the previous value was 0.7%. The monthly rate of wholesale inventory in Canada in October was 0.9%, and the previous value was 0.2%. The monthly inventory rate of manufacturing industry in Canada in October was 0.2%, and the previous value was -0.4%. The monthly rate of new manufacturing orders in Canada in October was -0.9%, and the previous value was 3.9%. The monthly rate of unfinished orders in Canada's manufacturing industry in October was -0.2%, and the previous value was 1.6%. Canada's capacity utilization rate in the third quarter was 79.3%, with an expected 78.9% and a previous value of 79.10%. Canada's manufacturing inventory shipment ratio in October was 1.69%, and the previous value was 1.74%.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.BYD Lian Yubo: It is estimated that BYD will sell 4.25 million vehicles in the whole year. On December 13th, BYD's chief scientist Lian Yubo said: "Up to now, BYD has sold more than 10 million new energy vehicles. By the end of this month, we can probably achieve the annual sales of 4.25 million vehicles. " He also mentioned: "There are still some challenges in industrial development. For example, the overall anti-risk ability of our industrial chain needs to be improved, and there are still breakthroughs in chips, operating technologies, industrial software and nuclear materials. We still need to strengthen research and achieve complete autonomy and controllability."